• Log in
Greater Manchester Medicines Management Group - GMMMG logo
  • Home
    • Homepage
    • News Summary
    • Consultations
  • Joint Formulary
    • BNF Chapters
    • Formulary Requests
  • RAG/DNP
    • RAG/DNP List
    • Paediatric RAG/DNP List
    • RAG Submissions
  • Shared Care
    • Approved Shared Care Protocols
  • GMMMG Guidance
    • Clinical guidance and pathways
    • Medicines and devices recommendations
    • Information leaflets for primary care prescribers
    • High cost drugs
    • Prescribing policies
    • Operational policies
  • Meetings
    • Membership and Terms of Reference
    • Decision Summaries
    • GMMMG Meetings
    • Medicines and Guidelines Subgroup
    • Clinical Reference Group
    • GMMMG Process Documents
    • Subgroup Meetings Archives
Home » Shared Care Protocols » SSRIs for the treatment of OCD and body dysmorphic disorder (BDD) in children and adolescents

SSRIs for the treatment of OCD and body dysmorphic disorder (BDD) in children and adolescents

GMMMG Consultations

Complete a consultation form »

GMMMG Members Area

Access members area »

Search GMMMG

Latest news

  • Consultations: DOAC statement and hypersalivation pathway

    June 2022

  • Updated antimicrobial guidance

    June 2022

  • Updated headache pathway

    June 2022

Tariff Watch

View key price changes in the drug tariff. »

Follow GMMMG on Twitter

  • Terms and Conditions
  • Contact
  • About us
  • RSS Feed